Ethyl arachidonate | CAS:1808-26-0

We serve Ethyl arachidonate CAS:1808-26-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ethyl arachidonate

Chemical Name: Ethyl arachidonate
Synonyms:5,8,11,14-Eicosatetraenoic acid ethyl ester,Arachidonic 
 
acid ethyl ester
Ethyl arachidonate
5,8,11,14-Eicosatetraenoic acid ethyl ester Arachidonic acid ethyl 
 
ester
ARACHIDONIC ACID ETHYL ESTER
 
CAS.NO: 1808-26-0
Molecular Formula: C22H36O2
Molecular Weight: 332.52000
 
Physical and Chemical Properties:
Density: 0.899g / cm3
Boiling point: 418.1ºC at 760mmHg
Flash point: 100.7ºC
Refractive index: 1.485
 
Specification:
Appearance:Yellow to orange-red transparent liquid
Purity:≥98%
 
Packing:5kg / 25kg / 50kg / 180kg fluorinated plastic barrel / 
 
galvanized barrel / aluminum barrel
Storage:Sealed storage at -20 ºC
Application:For the preparation of special organic chemicals.



Contact us for information like Ethyl arachidonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ARACHIDONIC ACID ETHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,8,11,14-Eicosatetraenoic acid ethyl ester Arachidonic acid ethyl Use and application,Ethyl arachidonate technical grade,usp/ep/jp grade.


Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.4-(2-methylpropyl)oxane-2,6-dione manufacturer Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.Veratraldehyde supplier With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.9,9,10-triphenyl-9,10-dihydroacridine vendor With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.